直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

In POSCO, Petitioner Prevails Due to Prior Parental Patent Proceeding

July 10, 2025

Authored and Edited by Forrest A. Jones; Joshua Everetts*

In POSCO Co., Ltd. v. Arcelormittal, IPR2025-00370, -00371, Paper 10 (PTAB Jun. 25, 2025), Acting USPTO Director Coke Morgan Stewart (Acting Director) referred both IPRs for institution because of the Petitioner’s settled expectations—the Petitioner had previously invalidated all claims of a parent of the challenged patents. This was despite multiple Fintiv considerations the Acting Director stated counseled for Discretionary denial.

Considerations Counseling for Discretionary Denial

The Acting Director identified two considerations that she stated favor discretionary denial.

First, the challenged patent was involved in a parallel ITC investigation. The Director noted that it was “unlikely that a final written decision in these proceeding[s] will issue before the conclusion of the ITC investigation.” In fact, approximately nine months was projected to pass between the expected conclusion of the ITC investigation and the final written decision issue date: the ITC target date was October 23, 2025, while the final written decision was expected on July 30, 2026.

Second, the Director found “substantial investment by the parties in the ITC proceeding.” The evidentiary hearing in the ITC investigation had concluded, and the parties had already completed post-hearing briefing for the investigation.

Considerations Counseling Against Discretionary Denial

However, two additional considerations outweighed these other considerations, counseling against discretionary denial.

First, the Acting Director found that the “Petitioner is not a party in the ITC investigation.” Instead, Petitioner’s customer, who was listed as a real party-in-interest in the Petition, was the actual party in the ITC proceeding.

Second, and most importantly, the Petitioner’s arguments regarding its own settled expectations “tip[ped] the balance against discretionary denial.” The Petitioner had previously invalidated all claims of the parent of both challenged patents in an IPR that concluded before the challenged patents issued. As such, the Petitioner properly expected the claims were “highly vulnerable to invalidation based on prior art.” The Director highlighted that “[i]t is an appropriate use of Office resources to provide consistency and predictability to the public, and to ensure that a patent applicant or owner does not take action inconsistent with the judgment in a prior Office proceeding.”

Unique Facts Can Outweigh Strong Fintiv Considerations

Parties should pay careful attention to the specific facts of their case. Even where there is a large difference between the end of the parallel litigation and the final written decision, other facts can still outweigh Fintiv and counsel referral. Petitioners should in particular look for previous errors by the Office, like the issuance of related patents after a parent was invalidated. And Patent Owners should pay careful attention to the full family of their patents and anticipate parental issues in their discretionary denial briefing.

Tags

discretionary denials, Fintiv, prior art

Related Practices

Global IP Enforcement, Litigation, and Trials

ITC Section 337 Investigations and Trials

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Offices

Washington, DC

Contacts

Forrest A. Jones
Partner
Washington, DC
+1 202 408 4019
Email

*Joshua Everetts is a Summer Associate at Finnegan.

Copyright © 2025 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Conference

2026 EDTX Bench Bar Conference

October 28-30, 2026

Fort Worth

Hybrid Conference

Intellectual Property Law Institute 2026 – California

October 19-20, 2026

San Francisco

Hybrid Conference

Intellectual Property Law Institute 2026 – New York

September 28-29, 2026

New York

Conference

2026 IPO Annual Meeting

September 27-29, 2026

Toronto

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Webinar

Inventive Step in Europe and the US: Comparing the UPC, EPO and National Approaches

July 8, 2026

Webinar

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Prosecution First Blog

USPTO Tightens “Unintentional Delay” Petitions — 1-Year Time Period Now Triggers Heightened Scrutiny

June 23, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP